These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5382012)

  • 21. [Therapeutic considerations on the hypoglycemic action of cyproheptadine (Periactin)].
    Castellar E; De Melo G; Sales R; Gonçalves A
    Hospital (Rio J); 1967 Nov; 72(5):1425-33. PubMed ID: 5307817
    [No Abstract]   [Full Text] [Related]  

  • 22. Glybenclamid (HB 419) and the prediabetes of subtotally pancreatectomized rats.
    Goberna R; Fussgänger RD; Raptis S; Ditschuneit H; Pfeiffer EF
    Horm Metab Res; 1969 Jul; 1(4):175-7. PubMed ID: 5003902
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of cyproheptadine on the rat lateral and ventromedial hypothalamus].
    Oomura Y; Ono T; Sugimori M; Nakamura T
    Nihon Seirigaku Zasshi; 1971 Mar; 33(3):193-205. PubMed ID: 5103678
    [No Abstract]   [Full Text] [Related]  

  • 24. Appetite stimulation and weight gain with cyproheptadine. A double-blind study in underweight children.
    Sanzgiri RR; Mohamad HA; Raja Z
    J Postgrad Med; 1970 Jan; 16(1):12-5. PubMed ID: 4913983
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of cyproheptadine on serum leptin levels.
    Calka O; Metin A; Dülger H; Erkoç R
    Adv Ther; 2005; 22(5):424-8. PubMed ID: 16418149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Body weight increase induced by cyproheptadine in a community of subnormal children].
    Pantarotto MF
    Clin Pediatr (Bologna); 1969 Dec; 51(12):785-98. PubMed ID: 5399502
    [No Abstract]   [Full Text] [Related]  

  • 27. Appetite stimulation and weight gain with cyproheptadine (periactin) in tuberculosis patients (double-blind clinical study).
    Rahman KM
    Med J Malaysia; 1975 Jun; 29(4):270-4. PubMed ID: 1105100
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review.
    Harrison ME; Norris ML; Robinson A; Spettigue W; Morrissey M; Isserlin L
    Appetite; 2019 Jun; 137():62-72. PubMed ID: 30825493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of cyproheptadine to obtain recovery of the weight curve after tonsillectomy. Clinico-statistical observations on 91 cases].
    Fior R
    Minerva Otorinolaringol; 1971; 21(5):191-5. PubMed ID: 5134405
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of cyproheptadine on glucose tolerance, serum insulin and structure of pancreatic islets in rats.
    Chakrabarty AS; Pourany A; Ananthanarayanan PH; Subramanian N; Rathinaswamy P; Chakrabarty K
    Indian J Exp Biol; 1990 Aug; 28(8):721-3. PubMed ID: 2253963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperinsulinemia after tolbutamide in mild glucose intolerance.
    Khurana RC; Robin JA; Jung Y; Corredor DG; Gonzalez A; Sunder JH; Danowski TS
    Horm Metab Res; 1971 Jul; 3(4):233-8. PubMed ID: 5129982
    [No Abstract]   [Full Text] [Related]  

  • 32. Glucose tolerance in gestational diabetic women during and after treatment with a combination-type oral contraceptive.
    Szabo AJ; Cole HS; Grimaldi RD
    N Engl J Med; 1970 Mar; 282(12):646-50. PubMed ID: 5417729
    [No Abstract]   [Full Text] [Related]  

  • 33. [Carbohydrate and fat metabolism in diabetic and nondiabetic patients with arteriosclerosis].
    Geser CA; Ziegert V; Hess H; Mehnert H
    Med Klin; 1970 Apr; 65(14):664-8. PubMed ID: 5507800
    [No Abstract]   [Full Text] [Related]  

  • 34. [The course of insulinaemia and the results of carbohydrate tolerance tests in obesity (author's transl)].
    Sieradzki J; Szybiński Z; Mruk K; Huszno B; Gabryelski W; Golda W
    Przegl Lek; 1974; 31(6):610-7. PubMed ID: 4849891
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral glucose-stimulated insulin release in nondiabetic twin siblings of diabetic twins.
    Gottlieb MS; Soeldner JS; Kyner JL; Gleason RE
    Diabetes; 1974 Aug; 23(8):684-92. PubMed ID: 4853483
    [No Abstract]   [Full Text] [Related]  

  • 36. Carbohydrate metabolism in previable fetal death.
    Goldman JA; Resnik R
    Am J Obstet Gynecol; 1974 Aug; 119(8):1083-90. PubMed ID: 4847443
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the clinical use of cyproheptadine as an anti-anorexic agent and its effects on the nutritional state].
    Martino A; Musella U; Ruffolo A
    Minerva Med; 1971 May; 62(38):1941-6. PubMed ID: 5281062
    [No Abstract]   [Full Text] [Related]  

  • 38. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial.
    Heiskanen MA; Motiani KK; Mari A; Saunavaara V; Eskelinen JJ; Virtanen KA; Koivumäki M; Löyttyniemi E; Nuutila P; Kalliokoski KK; Hannukainen JC
    Diabetologia; 2018 Aug; 61(8):1817-1828. PubMed ID: 29717337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the insulin response to glucose after treatment with cyproheptadine.
    Golander A; Spirer Z
    Acta Paediatr Scand; 1982 May; 71(3):485-7. PubMed ID: 6753477
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of moderate and high doses of human growth hormone on the insulin response to glucose infusion in prediabetic subjects.
    Luft R; Cerasi E; Werner S
    Horm Metab Res; 1969 May; 1(3):111-5. PubMed ID: 5407077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.